Business Wire

Keeper Security: New report reveals significant cybersecurity pressures on UK businesses

9.7.2021 10:00:00 EEST | Business Wire | Press release

Share

UK businesses are struggling to deal with multiple urgent cybersecurity challenges, new research by Keeper Security has revealed. The 2021 Cybersecurity Census Report shows cyberattacks are becoming more vicious, frequent and sophisticated, while UK businesses are underprepared and too slow to counter these attacks. As a result, senior leaders within UK organisations are preoccupied with playing a cyberattack blame game instead of investing in boosting their defences.

The report has found that more than nine in ten (92%) UK business suffered a cyberattack in the last 12 months and three quarters (78%) feel unprepared to deal with this threat. Nearly a third (31%) believe CTOs should take the blame in the case of a successful cyberattack. Such a weight of responsibility means cybersecurity standards are dropping: 36% of senior IT leaders confess to having kept a cyberattack to themselves, while 32% admit to using weak credentials such as ‘password’ or ‘admin’ to protect their data.

“UK businesses are clearly worried about their cybersecurity and, as our report has found, the challenges are manifold, affecting everything from budgets to productivity,” said Darren Guccione, CEO & co-founder, Keeper Security. “While there is a desire to boost security efforts, companies are facing many competing challenges right now and, understandably, might not always make cybersecurity investments a priority. Our report is an urgent reminder for organisations to proactively address their cybersecurity challenges as a priority since deferring them will make the consequences far more severe.”

Key findings include:

  • Almost all (92%) UK organisations are aware of gaps or weak links in their cybersecurity defences are, but less than half (40%) are actively addressing all of them
  • Two-thirds (66%) of UK organisations have relaxed their cybersecurity policies over the past 12 months so staff can work remotely or in order not to stifle productivity
  • 58% of IT professionals feel employees at their organisations do not understand the full consequences of poor cyber-hygiene
  • 61% of UK companies have a skills shortage in cybersecurity
  • The financial fallout of cyberattacks has been damaging, too, costing nearly one in ten (8%) UK businesses over £1 million
  • An overwhelming 87% of IT leaders support the creation of a nationwide governing body to hold businesses to account when it comes to best online security practices
  • And almost all (91%) are in agreement that UK businesses should be legally required to have basic cybersecurity protections in place to be allowed to operate

“Companies are struggling to put the right solutions in place to cope with cyberattacks and the consequences are both damaging and costly,” said Craig Lurey, CTO and co-founder, Keeper Security. “The conditions caused by Covid-19 have led to an increased amount of hybrid working, making effective cybersecurity defences even harder to achieve. But if businesses want to bounce back fully after the pandemic, they must get their security hygiene in order without delay.”

Despite the rise in cyberattacks and increasing pressures felt by security teams, more than a quarter of UK companies (28%) do not consider IT to be even in their top three priorities as they plan for the next 12 months. This is particularly worrying, given almost all (92%) UK organisations know where the gaps or weak links in their cybersecurity defences are but well under half (40%) are actively addressing them.

Guccione concludes: “While this situation can't be rectified overnight, there are straightforward steps UK businesses can take to boost their cyber defences. First, organisations should do a comprehensive cybersecurity audit, looking at where the gaps lie and how they can be addressed. Next, they need to put in place a clear plan of action for how to address these challenges. Running cybersecurity training sessions to educate employees and introducing a password management platform to keep credentials safe and secure are two simple, yet highly effective actions business can take today, to be better prepared against cyberattacks tomorrow.”

+++ ENDS +++

About Keeper Security Inc.

Keeper Security, Inc. (Keeper) is the highly-rated and patented cybersecurity platform for preventing password-related data breaches and cyberthreats. Keeper’s zero-knowledge security and encryption software is trusted by millions of people and thousands of businesses across the globe to mitigate the risk of cybertheft, boost employee productivity and meet compliance standards. Keeper has been named PC Magazine’s Best Password Manager of the Year & Editors’ Choice, PCWorld’s Editors’ Choice and is the winner of four G2 Best Software Awards and the InfoSec Award for Best Product in Password Management for SMB Cybersecurity. Keeper is SOC-2 and ISO 27001 Certified and is also listed for use by the U.S. federal government through the System for Award Management (SAM). Learn more at https://keepersecurity.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PR contact:
Tara Geoghegan
tara.geoghegan@archetype.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye